ArticleBioinformatics (Oxford, England)2025
Trustworthy causal biomarker discovery: a multiomics brain imaging genetics-based approach.
Article in Bioinformatics (Oxford, England), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Mutual learning for joint disease detection and severity prediction reveals multimodal pathogenesis for neurodegenerative disorders.Bioinformatics (Oxford, England) · 2026Article
- How gut microbiota contribute to neuropsychiatric disorders: evidence from neuroimaging studies.Frontiers in microbiology · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
motivationDiscovering genetic variations underpinning brain disorders is important to understand their pathogenesis. Indirect associations or spurious causal relationships pose a threat to the reliability of biomarker discovery for brain disorders, potentially misleading or incurring bias in subsequent decision-making. Unfortunately, the stringent selection of reliable biomarker candidates for brain disorders remains a predominantly unexplored challenge.
resultsIn this article, to fill this gap, we propose a fresh and powerful scheme, referred to as the Causality-aware Genotype intermediate Phenotype Correlation Approach (Ca-GPCA). Specifically, we design a bidirectional association learning framework, integrated with a parallel causal variable decorrelation module and sparse variable regularizer module, to identify trustworthy causal biomarkers. A disease diagnosis module is further incorporated to ensure accurate diagnosis and identification of causal effects for pathogenesis. Additionally, considering the large computational burden incurred by high-dimensional genotype-phenotype covariances, we develop a fast and efficient strategy to reduce the runtime and prompt practical availability and applicability. Extensive experimental results on four simulation data and real neuroimaging genetic data clearly show that Ca-GPCA outperforms state-of-the-art methods with excellent built-in interpretability. This can provide novel and reliable insights into the underlying pathogenic mechanisms of brain disorders. AVAILABILITY AND IMPLEMENTATION: The software is publicly available at https://github.com/ZJ-Techie/Ca-GPCA.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.